Oncology
Rinath Jeselsohn, M.D.
Researcher Physician, Director for ER+ Translational Discovery Research, Assistant Professor of Medicine at Harvard Medical School
Rinath M. Jeselsohn, MD, is a breast medical oncologist and physician scientist at Dana-Farber Cancer Institute in Boston, MA. She specializes in treating hormone receptor-positive breast cancer, with a focus on metastatic disease and mechanisms of acquired endocrine resistance. Her research has identified estrogen receptor (ER) mutations as the most common genetic cause of resistance to endocrine therapies in metastatic ER-positive breast cancer, leading to the development of novel endocrine ag
25+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (2008)
- Internal Medicine (2005)
Education & Training
- Hebrew University — M.D.
- University of Texas San Antonio Health Science Center — Residency, Internal Medicine
- University of Massachusetts — Internal Medicine Residency
- Tufts Medical Center — Fellowship, Hematology/Oncology
Recognition & Leadership
Awards & Honors
- Barr Award
- Dunkin Donut Drives Cancer breakthrough award
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
Languages
English
Experience
25+ years in practice